Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis

Ben Z. Katz, Steven Boas, Yukiko Shiraishi, Cynthia J. Mears, Renee Taylor

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Objective: Six months after acute infectious mononucleosis (IM), 13% of adolescents meet criteria for chronic fatigue syndrome (CFS). We measured exercise tolerance in adolescents with CFS and control subjects 6 months after IM. Study design: Twenty-one adolescents with CFS 6 months after IM and 21 recovered control subjects performed a maximal incremental exercise tolerance test with breath-by-breath gas analysis. Values expressed are mean ± standard deviation. Results: The adolescents diagnosed with CFS and control subjects did not differ in age, weight, body mass index, or peak work capacity. Lower oxygen consumption peak percent of predicted was seen in adolescents with CFS compared with control subjects (CFS 99.3 ± 16.6 vs control subject 110.7 ± 19.9, P = .05). Peak oxygen pulse also was lower in adolescents with CFS compared with recovered control subjects (CFS 12.4 ± 2.9 vs control subjects 14.9 ± 4.3, P = .03). Conclusions: Adolescents with CFS 6 months after IM have a lower degree of fitness and efficiency of exercise than recovered adolescents. Whether these abnormal exercise findings are a cause or effect of CFS is unknown. IM can lead to both fatigue and measurable changes in exercise testing in a subset of adolescents.

Original languageEnglish (US)
Pages (from-to)468-472+472.e1
Journaljournal of pediatrics
Volume157
Issue number3
DOIs
StatePublished - Sep 2010

Keywords

  • CFS
  • Chronic fatigue syndrome
  • IM
  • Infectious mononucleosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis'. Together they form a unique fingerprint.

Cite this